Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2025

Jun 26, 2025

33899_dirs_2025-06-26_fa615190-bd2d-44d3-b069-64103b8ead73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2025-06-25

Reporting Person: BROWN JEFFREY J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-06-25 Common Stock A 11167.542 Acquired 29128.189 Direct
2025-06-25 Common Stock A 9449.458 $13.39 Acquired 38577.647 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4232.967 Indirect

Footnotes

F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.

F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.

F3: The price per share of $13.39 is based on the 20-day moving average stock price of the Issuer's common stock as of June 6, 2025.

F4: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.